Vasopressin Receptor Expression and Mutation Analysis in Corticotropin-Secreting Tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 5, 1996, Pages 1768-1771

  Dahia, P L M ^a   Ahmed Shuaib, A ^a   Jacobs, R A ^a   Chew, S L ^a   Honegger, J ^b   Fahlbusch, R ^b   Besser, G M ^a   Grossman, A B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DESMOPRESSIN; HYDROCORTISONE; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V3 RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CUSHING DISEASE; ECTOPIC CORTICOTROPIN PRODUCTION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PITUITARY NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, VASOPRESSIN;

EID: 0029930209     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.5.8626831     Document Type: Article

References (25)

1. De Bold CR, Sheldon WR, De Cherney GS, et al. 1984 Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest. 73:533-538.
2. Malerbi DA, Mendonça BB, Liberman B, et al. 1993 The desmopressin stimulation test in the differential diagnosis of Cushing's disease. Clin Endocrinol (Oxf). 38:463-472.
3. Thibonnier M, Auzan C, Madhun Z, Wilkins P, Berti-Mattera L, Clauser E. 1994 Molecular cloning, sequencing and functional expression of a cDNA encoding the human V1a vasopressin receptor. J Biol Chem. 269:3304-3310.
4. Birnbaumer M, Seibold A, Gilbert S, et al. 1992 Molecular cloning of the receptor for human antidiuretic hormone. Nature. 357:333-335.
5. Antoni FA. 1984 Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology. 39:186-188.
6. Antoni FA. 1987 Receptors mediating the CRH effects of vasopressin and oxytocin. Ann NY Acad Sci. 512:195-204.
7. Spiegel RM, Weinstein LS, Shenker A. 1993 Abnormalities in G protein-coupled signal transduction pathways in human disease. J Clin Invest. 92: 1119-1125.
8. Sugimoto T, Sato M, Mochizuki S, et al. 1994 Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem. 269:27088-27092.
9. De Keyzer Y, Auzan C, Lenne F, et al. 1994 Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett. 356:215-220.
10. Trainer PJ, Grossman A. 1991 The diagnosis and differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf). 34:317-330.
11. Trainer PJ, Faria M, Newell-Price J, et al. 1994 A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J Clin Endocrinol Metab. 80:412-417.
12. Chew SL, Lavender P, Jain A, et al. 1995 Absence of mutations in the MEN2A region of the ret proto-oncogene in non MEN2A phaeochromocytomas. Clin Endocrinol (Oxf). 42:17-21.
13. Latronico AC, Reincke M, Mendonça BB, et al. 1995 No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. J Clin Endocrinol Metab. 80:875-877.
14. Dahia PLM, Aguiar RCT, Tsanaclis AM, et al. 1995 Molecular and immunohistochemical analysis of p53 in phaeochromocytomas. Br J Cancer. 72: 1211-1213.
15. Kovacs K, Horvath E. 1990 Morphology of the pituitary in health and disease. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. Philadelphia: Lipincott; 109-124.
16. Herman V, Fagin JA, Gonsky R, Kovacs K, Melmed S. 1990 Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 71:1427-1433.
17. Herman V, Drazin NZ, Gonsky R, Melmed S. 1993 Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab. 77:50-55.
18. Levy A, Hall L, Yeudall WA, Lightman SL. 1994 p53 gene mutations in pituitary adenomas: rare events. Clin Endocrinol (Oxf). 41:809-814.
19. Sawyer WH, Acosta M, Manning M. 1974 Structural changes in the AVP molecule that prolong its antidiuretic action. Endocrinology. 95:140-149.
20. Buckingham JC. 1987 Vasopressin receptors influencing the secretion of ACTH by the rat adenohypophysis. J Endocrinol. 113:389-396.
21. Aguilera G, Pham Q, Rabadan-Diehl C. 1994 Regulation of pituitary vasopressin receptors during chronic stress: relationship to corticotroph responsiveness. J Neuroendocrinol. 6:299-304.
22. Rabadan-Diehl C, Lolait SJ, Aguilera G. Regulation of pituitary vasopressin receptor (V1b) mRNA by adrenalectomy and glucocorticoids [Abstract P1-570]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995.
23. Antoni FA, Holmes MC, Kiss JZ. 1985 Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats. Endocrinology. 117:1293-1299.
24. Bernardini R, Chiarenza A, Kamilaris T, et al. 1994 In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology. 60:503-508.
25. Lolait SJ, O'Carroll AM, Mahan LC, et al. 1995 Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci USA. 92: 6783-6787.